SUNY Upstate seeks trial participants

The trial is being supported through the ALS Association's TREAT ALS (Translational Research Advancing Therapies for ALS) initiative, a drug discovery program and clinical trials process created by the association that accelerates discovery and testing of clinical candidates. In addition to SUNY Upstate, investigators from Massachusetts General Hospital, the University of Toronto and Columbia University will participate in the trial.

ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Motor neurons reach from the brain to the spinal cord and from the spinal cord to the muscles throughout the body. When the motor neurons die, the ability of the brain to initiate and control muscle movement is lost, leading to progressive paralysis.

For more information about the study or to participate in the study, call 464-5004.

Vote on this Story by clicking on the Icon


Use the comment form below to begin a discussion about this content.

Sign in to comment